Cargando…
L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin
BACKGROUND: Autotaxin (ATX, NPP-2), originally purified as a potent tumor cell motility factor, is now known to be the long-sought plasma lysophospholipase D (LPLD). The integrity of the enzymatic active site, including three crucial histidine moieties, is required for motility stimulation, as well...
Autores principales: | Clair, Timothy, Koh, Eunjin, Ptaszynska, Malgorzata, Bandle, Russell W, Liotta, Lance A, Schiffmann, Elliott, Stracke, Mary L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC554093/ https://www.ncbi.nlm.nih.gov/pubmed/15737239 http://dx.doi.org/10.1186/1476-511X-4-5 |
Ejemplares similares
-
Novel point mutations attenuate autotaxin activity
por: Koh, Eunjin, et al.
Publicado: (2009) -
Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
por: Ramesh, Sindhu, et al.
Publicado: (2018) -
Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
por: She, Sha, et al.
Publicado: (2022) -
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
por: Valdés-Rives, Silvia Anahi, et al.
Publicado: (2017) -
Linking medicinal cannabis to autotaxin–lysophosphatidic acid signaling
por: Eymery, Mathias C, et al.
Publicado: (2023)